EyePod: Recent Episodes
EyePod
This audible resource from Ophthalmology Times engages with key opinion leaders in interviews about the latest innovations in the areas of surgery, clinical diagnosis, pharmaceutical advancements, research, and technology, plus practice management.
Take a look at a review of the highlights from Ophthalmology Times during the week of September 29, 2024.
Take a look at a review of the highlights from Ophthalmology Times during the week of September 22, 2024.
Ehsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, Department of Ophthalmology, Faculty of Medical and Health Sciences, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias.
Green outlines the status of the research, involving a unique combination of transforming growth factor beta-3 and dexamethasone, and the setup for a proof-of-concept study (via TheiaNova, a spin-out early-stage company of the University of Auckland).
Green also offers career advice for vision scientists and entrepreneurs, advising that making the transition from basic research to research translation is challenging and that having an application in mind is crucial. He emphasizes the importance of persevering through the highs and lows of research and development, highlighting the long-term benefits and sense of achievement.
Take a look at a review of the highlights from Ophthalmology Times during the week of September 15, 2024.
X-linked retinitis pigmentosa (XLRP) is a progressive disease that is more severe than other forms of RP. Affected male patients typically inherit a pathogenic variant of the RPGR gene on the X chromosome. In this podcast, an expert panel discusses diagnosing XLRP and provides an overview of clinical trials of gene therapies for XLRP.
Thyroid eye disease is a condition frequently associated with Graves disease that involves both acute and chronic inflammation of the orbit. Patients may experience ocular discomfort, appearance changes, and vision loss. In this podcast, an expert panel discusses diagnosing TED and providing appropriate pharmacologic and surgical treatments.
John Kitchens, MD, is joined by Peter Kaiser, MD, to discuss higher molar dose and its translation into clinical practice
This PER On Air - Ophthalmology Times podcast examines the new treatment paradigm for patients with geographic atropy, following the introduction of complement-targeting therapies. In this podcast, experts, Dr Cecelia Koetting and Dr Talia Kaden review some of the key highlights from the live satellite symposium, Community Practice Connection™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention presented at the 2024 EnVision Summit in Ophthalmology.
In this PER On Air Ophthalmology Times podcast, a team of experts provides insights into the diagnosis and management of patients with NK (including assessing their underlying cause of NK), with a look at the range of treatments available for patients with advanced stages of NK.
In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment.Faculty:Roger A. Goldberg, MD, MBAVitreoretinal SpecialistBay Area Retina AssociatesVolunteer FacultyCalifornia Pacific Medical CenterWalnut Creek, CADavid R.P. Almeida, MD, PhD, MBAPresident and CEOErie Retina ResearchCenter for Advanced Surgical ExplorationErie, PAJennifer I. Lim, MD, FARVOMarion H. Schenk Esq. Chair in Ophthalmology for Research of the Aging EyeUIC Distinguished Professor of OphthalmologyDirector, Retina ServiceVice-Chair, Diversity and InclusionUniversity of Illinois at ChicagoChicago, IL
In this Ophthalmology Times EyePod podcast, Mandeep S. Singh, MD, PhD, speaks with Mark S. Humayun, MD, PhD, to discuss the progress in developing a stem cell patch for treating advanced dry age-related macular degeneration. Developed by a team of researchers at USC, the stem cell patch represents a significant advancement in treatment. Dr. Humayun talks about the inspiration behind the patch, how his expertise in both ophthalmology and biomedical engineering has been crucial, and insights gained from a Phase 1/2a study. Dr. Humayun also outlines the upcoming steps for a multisite Phase 2b clinical trial and envisions the potential future role of the stem cell patch in the treatment of geographic atrophy.
This podcast features engaging commentary from experts in the clinical management of glaucoma. These experts share information about traditional and newer therapies for glaucoma, including topical drops, sustained drug delivery options, and minimally invasive glaucoma surgery. They discuss safety and efficacy data with an emphasis on appropriate patient selection, as well as key take-home points and practice pearls.
The role of calendars may be growing more important when managing patients with nAMD and DME. How many weeks can patients go between injections with newer anti-VEGF agents versus older options? How short of an injection interval can patients tolerate before it becomes too much of a burden?In this podcast, Murtaza Adam, MD; Laxmi Devisetty, MD, Hong-Uyen Hua, MD; and Sherrol Reynolds, OD; share insights into determining appropriate treatment regimens with these therapies and supporting patient adherence.Faculty Credentials:Murtaza Adam, MDPartner PhysicianChair, Clinical Research CommitteeColorado Retina AssociatesAdjunct Clinical Associate ProfessorRocky Vista UniversityDenver, COLaxmi V. Devisetty, MDOphthalmologistRetina SpecialistVitreoretinal SurgeonNJRetinaUnion, New JerseyHong-Uyen Hua, MDAssistant Professor of Clinical OphthalmologyPediatric and Adult Retina SpecialistBascom Palmer Eye InstituteUniversity of Miami Health SystemMiami, FLSherrol A. Reyn
Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis
Tune in to the first of a new series of Ophthalmology Times EyePod podcasts focusing on innovation in ophthalmology. Throughout this series, we'll be hearing insights from various stakeholders including those in clinical practice, academia, and industry. The overarching message in this podcast is intended to be informational and not promotional. Today, our host Ehsan Sadri, MD, will be in conversation with Jeffry Weinhuff, who is managing partner of Visionary Ventures. And just a quick note: the thoughts and opinions expressed are those of the speakers and do not necessarily represent the opinions of this publication.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of December 17, 2023.
In this episode of EyePod, David Hutton sits down with Neena Haider, PhD, and Arun Upadhyay, PhD, to talk about modifier gene therapy.
Take a look at a review of the highlights from Ophthalmology Times during the week of January 21, 2024.
Take a look at a review of the highlights from Ophthalmology Times during the week of January 7, 2024.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of December 17, 2023.
Explore the practical side of femtosecond laser-assisted cataract surgery (FLACS) with Neda Shamie, MD, and Peter J. McDonnell, MD. In this podcast, they discuss real-world experiences, patient choices, and the nuances of integrating FLACS into practice, offering insights into the latest developments in ophthalmology.
In this episode, Neda Shamie, MD, and Peter J. McDonnell, MD, discuss the benefits and challenges of implementing the many options from the premium lens pipeline into practice, emphasizing the importance of customization based on patients' lifestyles and expectations, while also addressing concerns and sharing their positive experiences with the evolving technology in the field.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of December 2, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of November 12, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of November 12, 2023.
Peter J. McDonnell, MD, and Neda Shamie, MD, consider the transformative landscape of cataract surgery, highlighting the impact of small-aperture IOL technology. The conversation delves into its potential benefits, influence on the market, and the evolving role of cataract surgeons in guiding patients through advanced options.
Welcome to this special edition of the Ophthalmology Times® EyePod recorded in conjunction with Physicians’ Education Resource. This podcast features an international panel of ophthalmologists, including Arshad M. Khanani, MD, MA, FASRS; Carl J. Danzig, MD, FASRS; and Anat Loewenstein, MD, MHA, who will discuss unmet needs in the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) — and opportunities for extended treatment intervals that newer agents might provide. This program is designed to help clinicians better appreciate limitations of traditional anti-VEGF agents and optimize the growing toolkit of available therapies.
Welcome to this special edition of the Ophthalmology Times® EyePod recorded in conjunction with Physicians’ Education Resource. This podcast examines how key therapies for treating diabetic macular edema—anti-VEGF agents and corticosteroids—address the underlying pathophysiology of the condition to effectively and safely treat it. In this podcast, 3 ophthalmologists—Fernando Arevalo, MD; Peter Kaiser, MD; and Nathan Steinle, MD—share their insights to help you optimize care for your patients with this common diabetes-related eye disease.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of October 1, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of September 24, 2023.
In this EyePod® episode, David Hutton sits down with Shankar Musunuru, CEO of Ocugen to discuss updated data for OCU400.
Peter J. McDonnell, MD, and Neda Shamie, MD, discuss the transformative impact of minimally invasive glaucoma surgery (MIGS) on glaucoma care and its integration with cataract surgery, sharing insights and practical tips for ophthalmologists.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of September 17, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of September 10, 2023.
Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 4 of the Viewpoints Podcast.
Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 3 of the Viewpoints Podcast.
Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 2 of the Viewpoints Podcast.
In this podcast, Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of September 3, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of August 27, 2023.
In this episode, Ophthalmology Times' co-chief medical editors Peter J. McDonnell, MD, and Neda Shamie, MD, delve into the clinical nuances of Demodex blepharitis. Through personal anecdotes, they stress its underrecognized gravity and discuss diagnostic cues like collarettes. The experts share their enthusiasm for improved treatments, echoing the transformative impact seen in dry eye care.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of August 20, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of August 13, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of August 6, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of July 30, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of July 16, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of July 9, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
Take a look at a review of the highlights from Ophthalmology Times during the week of July 2, 2023.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
In the sport, which is a hybrid of badminton, ping-pong and tennis, players use a plastic-perforated ball, slightly heavier than a whiffle ball, and wooden or composite paddles that are about twice the size of ping-pong paddles, with a high potential for eye injuries.
Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.
A new study found an approach that identifies high-risk patients so all preemies don’t need to undergo an invasive eye exam.
William B. Trattler, MD, highlights some of the novel therapies for dry eye that have recently been approved by the FDA, along with various treatment approaches that are in development.
David Hutton from Ophthalmology Times and Jay Duker talk about wet AMD and the burdens of treatment on patients thanks to the consistent need for follow-ups and more.
Eyenuk Inc. founder and CEO Kaushal Solanki, PhD, went from working for the Defense Department to founding a company with a focus on artificial intelligence for ophthalmology. Find out what led him to make that jump.
Ehsan Sadri, MD, FACS, and William Trattler, MD, highlight some of the pending FDA approvals and PDUFA dates in the anterior segment sector and what these products will mean for ophthalmologists and their patients.
Dr. Jai Parekh, a clinical associate professor of Ophthalmology/The New York Eye & Infirmary of the Mount Sinai School of Medicine and David Hutton, Managing Editor of Ophthalmology Times discuss the importance of ocular health prior to cataract and refractive surgery, specifically with osmolarity testing.
On this part two episode with Colin Carr, founder and CEO of CARR, we hear more about commercial real estate dos and don'ts when managing the space of your practice. Tune in now for the discussion with Ophthalmology Times® executive editor, David Hutton.
Colin Carr, founder and CEO of CARR, chats with Ophthalmology Times' David Hutton in this part one episode of the EyePod. Colin hits on some hot real estate topics in the healthcare industry, including top mistakes healthcare providers make with their office space, how to decide whether you're going to purchase or lease, and how healthcare providers can save $100k or more on their next lease renewal.
In this episode of EyePod, Ora Clinical’s Keith Lane discusses uveitis and flare ups, as well as challenges in clinical trials.
Keith Lane of Orange Clinical joins us to discuss the current state of gene therapy and its standardized endpoints, and the challenges gene therapy has faced, particularly in relation to ophthalmology.
Retinopathy of prematurity expert C. Armitage Harper, III, MD, of the Austin Retina Associates in Austin, Texas, discusses his experience in treating ROP cases across the globe, and his mission prevent pre-term blindness in infants.
George O. Waring IV, MD, FACS, discusses the latest results from the GEMINI 1 clinical trial (by Allergan, an Abbvie company) of AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia.
Michael Rivers, MD, director of Ophthalmology at Modernizing Medicine, discusses Aetna's new policy requiring prior authorization for cataract surgery, its impact on ophthalmologists and patients, as well as potential solutions — and additional issues — that may arise in the future as a result.
Elizabeth Yeu, MD, a cornea cataract and refractive surgeon at Virginia Eye Consultants shares results from the Saturn 1 pivotal phase 2b3 trial evaluating the safety and efficacy of a new investigational therapeutic from Tarsus Pharmaceuticals called TP03 (lotilaner ophthalmic solution 0.25%), for the treatment of patients diagnosed with Demodex blepharitis.
Uday Devgan, MD, FACS, of Devgan Eye Surgery in Los Angeles and Beverly Hills, CA, answers a few key questions his patients have asked when considering cataract surgery.
Thomas Brunner, president & CEO, Glaucoma Research Foundation, San Francisco, CA, shares his thoughts on how living through a pandemic has influenced and altered his perspective on life — both personally and professionally — for the better.
Oluwatosin U. Smith, MD, Glaucoma Associates of Texas, offers an update on optimization and surgical modifications of newer glaucoma surgeries in preop and postop settings.
Ophthalmology Times®' Sheryl Stevenson speaks with Marc Mathias, MD, a retinal specialist from Children’s Hospital Colorado, who offers insight on managing cases of inherited retinal dystrophies in pediatric patients, as well as an update on the rapidly changing treatment landscape, thanks to ongoing clinical trials in novel IRD and genetic therapies.
Peter J. Polack, MD, FACS, and Zora Harrison, COO at Ocala Eye in North Central Florida, share the protocols and technology their practice implemented throughout the pandemic that has enabled them to safely and efficiently treat their patients.
Mary Elizabeth Hartnett, MD, FACS, FARVO, a distinguished professor in Ophthalmology and Visual Sciences, University of Utah, as well as director of Pediatric Retina at the John A. Moran Eye Center, and Mark Breazzano, MD, a vitreous and retinal surgeon at the Wilmer Eye Institute, Johns Hopkins University, analyze two areas of AMD relevant to today's field:
Dr. Hartnett highlights current research being conducted on the pathophysiology of AMD involving very long chain polyunsaturated fatty acids and new mechanism for fibrosis and neovascular AMD. Dr. Breazzano discusses how the COVID-19 pandemic has altered how ophthalmologists treat wet AMD, and how physicians can maximize their patient outcomes.
Sahar Bedrood, MD, PhD, a glaucoma/cataract specialist at Acuity Eye Group (Pasadena, CA), and a clinical assistant professor at USC Roski Eye Institute, shares her clinical perspective on the multi-faceted, dynamic evolution of interventional glaucoma.
John H. Merey, MD, possibly one of the last Holocaust survivors still in the practice of ophthalmology, shares his experience.
Thomas Samuelson, MD, speaks on the outcomes of a three-year trial analyzing the iStent inject trabecular micro-bypass + phaco versus phaco alone in patients with POAG.
Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.
Anne L. Coleman, MD, PhD, president of the American Academy of Ophthalmology (AAO), offers a preview of what attendees can look forward to from the academy's 2020 virtual annual meeting — kicking off Nov. 13-15 —including: in-depth information and innovations, free entry to the 17th annual Orbital Gala, open access to all 8 subspecialty days, new innovations, a first-ever talent show, extended access to content, and much more.
John J. Grande, CFP, and John S. Grande, CFP, of Grande Financial Services, discuss how having a solid financial plan in place can ease anxiety amid the ongoing coronavirus pandemic and ahead of a potential second wave, advice to ophthalmologists contemplating retirement,as well as the financial repercussions the economy may face heading into 2021.
Ranya Habash, MD, medical director, Technology Innovation, Bascom Palmer Eye Institute, University of Miami, speaks with Ophthalmology Times®' Sheryl Stevenson on the capabilities of telemedicine available to ophthalmologists, the impact of the pandemic in regards to FDA regulations and how it’s helped to pave the way forward / expand telemedicine, as well as why the future of telemedicine requires a new way of thinking.
S.K. Steven Houston III, MD, speaks with Ophthalmology Times®' Sheryl Stevenson on how his practice has put to use recent retina innovations and adapted to accommodate the ever-changing operating room spacing and set-up in the current COVID-19 environment.
Dilraj Grewal, MD, associate professor of ophthalmology at Duke Eye Center/ director of grading at the Duke Reading Center, speaks with Ophthalmology Times®' David Hutton on his presentation "Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis Following an Injectable Fluocinolone Acetonide Insert (FAi)," during the virtual 2020 American Society of Retina Specialists (ASRS) meeting.
Victor Gonzalez, MD, speaks with Ophthalmology Times® David Hutton on the highlights of his presentation regarding "Two-year outcomes from the PALADIN Phase 4 study: Anatomic/functional changes and reduced treatment frequency associated with 0.19 mg of fluocinolone acetonide implant (FAc) with persistent or recurrent diabetic macular edema," during the 2020 Association for Research in Vision and Ophthalmology (ARVO) virtual meeting.
Dee Stephenson, MD, ABO, speaks with Ophthalmology Times'® David Hutton on the highlights of her presentation "Early Clinical Assessment of Aberration Neutral One-Piece Monofocal Toric IOL with Enhanced Optic Recovery and Alignment ORA" during the 2020 ASCRS virtual meeting.
John Berdahl, MD, of Vance Thompson Vision, speaks with Ophthalmology Times'® David Hutton on the highlights of his presentation "Ocular Surface Disease Improvement in Eyes Implanted with Trabecular Meshwork Bypass Stents (iStent or iStent inject)," during the 2020 ASCR virtual meeting.
Soroosh Behshad, MD, MPH, of the Emory Eye Center, speaks with Ophthalmology Times'® David Hutton on the key takeaways from the presentation on, "Corneal crosslinking outcomes in children with progrssive keratoconus," during the 2020 ASCRS virtual meeting.
Julianne Matthews, MD, MPH, a resident at The Ohio State University, speaks with Ophthalmology Times'® David Hutton on the key highlights from her presentation "How Long Does It Take for Bcva, Kmax, and Pachymetry to Return to Baseline after Corneal Collagen Crosslinking for Keratoconus?," during the 2020 ASCRS virtual meeting.
Alice Epitropoulos, MD, FACS, from The Cataract & Refractive Center of Ohio, speaks with Ophthalmology Times'® David Hutton on the key highlights from her presentation "Image quality or depth of field or both: Clinical outcomes from spherical aberration neutral monofocal toric IOL," during the 2020 ASCRS virtual meeting.